REQUEST A DEMO
Total
USD $0.00
Search more companies

Trinity Pharmaceuticals & Food Private Limited (India)

Main Activities: Seafood Product Preparation and Packaging
Full name: Trinity Pharmaceuticals & Food Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Trinity Pharmaceuticals & Food Private Limited is based in India, with the head office in Mumbai. The company operates in the Seafood Product Preparation and Packaging industry. It was incorporated on October 31, 2012. The company’s latest financial report indicates a net sales revenue increase of 2.76% in 2025. Over the same period, its total assets grew by 18.39%.

Legal Address
Office No 813 B Wing Kanakia Wall Street Andheri Kurla Road Chakala Andheri East
Mumbai; Maharashtra; Postal Code: 400093

Contact Details: Purchase the Trinity Pharmaceuticals & Food Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Trinity Pharmaceuticals & Food Private Limited report to view the information.
Financial Auditors:
Purchase the Trinity Pharmaceuticals & Food Private Limited report to view the information.
Incorporation Date:
October 31, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Trinity Pharmaceuticals & Food Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
2.76%
Total Operating Revenue
3.55%
Operating Profit
N/A
EBITDA
-88.47%
Net Profit/Loss for the Period
N/A
Total Assets
18.39%
Total Equity
-2.7%
Operating Profit Margin
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
16.3%
Quick Ratio
-0.32%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?